Answer given by Mrs Reding on behalf of the Commission (3 February 2011) The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) collects and analyses information on drug seizures, number of users, and drug prices through its national Reitox focal points. This EMCDDA information is collected at Member State level. In 2007 the Commission launched a study funded by the Drug Prevention and Information Programme http://ec.europa.eu/justice/funding/drugs/funding_drugs_en.htm on the functioning of global illicit drug markets A report on Global Illicit Drug Markets 1998-2007; Final report available at: http://ec.europa.eu/justice/doc_centre/drugs/studies/doc_drugs_studies_en.htm . Based on the result of this study, the Commission has launched a call for tender on further analysis of the EU illicit drugs market and responses to it, to be funded by the Crime Prevention Programme http://ec.europa.eu/home-affairs/funding/isec/funding_isec_en.htm; The deadline for applications was 8.12.2010, the study is expected to be completed 18 months from signing the contract in early 2011. . The Commission has recently adopted a Staff Working Document on improving the collection of data on drug markets, drug-related crime and drug supply reduction measures in the European Union SEC(2010)1216 final. , proposing a strategy to enhance the data collection in this area. One of the main proposals of the paper concerns the development of key indicators in the field of drug markets, drug-related crime and supply reduction. The development of key indicators will provide the basis for a structural monitoring of the size and characteristics of the EU drugs market in the future.